ReferenceID 5905
Oridonin induces the apoptosis of mucoepidermoid carcinoma cell lines in a myeloid cell leukemia‑1‑dependent manner
Int J Oncol
Oridonin, an active diterpenoid isolated from Rabdosia rubescens, has been reported to exhibit anticancer activities in several tumors. The aim of the present study was to investigate the anticancer effects and molecular
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 5905
- Evidence Id
- 22495
- Core Evidence Id
- 22495
- Source Reference Id
- 5068
- Herb2 Reference Id
- HBREF005865
- Subject Paper Key
- HBIN038254_32467983
- Pubmed Id
- 32467983
- Doi
- 10.3892/ijo.2020.5061
- Paper Title
- Oridonin induces the apoptosis of mucoepidermoid carcinoma cell lines in a myeloid cell leukemia‑1‑dependent manner
- Paper Abstract
- Oridonin, an active diterpenoid isolated from Rabdosia rubescens, has been reported to exhibit anticancer activities in several tumors. The aim of the present study was to investigate the anticancer effects and molecular mechanisms of oridonin in mucoepidermoid carcinoma (MEC). Treatment with oridonin induced the apoptosis of MC-3 and YD-15 cell and inhibited the expression of myeloid cell leukemia-1 (MCL-1) through the regulation of the protein level through post-translational regulation in these cell lines. Oridonin significantly increased the expression level of truncated Bid (t-Bid) as a downstream target of MCL-1 and subsequently decreased the mitochondrial membrane potential. The ectopic expression of MCL-1 protein was sufficient to reverse the induction of apoptosis and the increased t-Bid expression induced by oridonin in both cell lines. Taken together, these results suggest that oridonin exerts an apoptotic effect through the modulation of MCL-1 and t-Bid in human MEC cell lines and may thus be a potential anticancer drug candidate for the treatment of human MEC.
- Journal
- Int J Oncol
- Publish Year
- 2020
- Experiment Subject
- human; cell lines; human mec cell lines; yd-15 cell
- Experiment Type
- Cell Experiment
- Phenotype Related
- Tumors; Mucoepidermoid Carcinoma
- Paper Title Cn
- Paper Title En
- Oridonin induces the apoptosis of mucoepidermoid carcinoma cell lines in a myeloid cell leukemia‑1‑dependent manner
- Bilingual Status
- semi_complete